$0.55
-0.03 (-5.19%)
Open$0.59
Previous Close$0.58
Day High$0.59
Day Low$0.54
52W High$2.10
52W Low$0.57
Volume—
Avg Volume371.7K
Market Cap139.62M
P/E Ratio0.11
EPS$9.85
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+6,583.0% upside
Current
$0.55
$0.55
Target
$36.75
$36.75
$26.33
$36.75 avg
$40.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 40.60M | 42.46M | 39.37M |
| Net Income | -1,409,045 | -1,565,662 | -1,719,749 |
| Profit Margin | -3.5% | -3.7% | -4.4% |
| EBITDA | -2,559,719 | -2,552,246 | -2,827,370 |
| Free Cash Flow | -1,137,405 | -963,691 | -1,418,550 |
| Rev Growth | +15.5% | -1.3% | +12.3% |
| Debt/Equity | 0.48 | 0.77 | 0.57 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |